Antwerp

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia2 trials
• Acute myeloid leukaemia1 trial
• Childhood cancers1 trial
• Familial hypercholesterolaemia1 trial
• Myeloproliferative neoplasms1 trial
• Thalassaemia1 trial

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals3 trials

Running trials

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  CINC424A2X01B Rollover Protocol

  NCT02386800· Phase 4· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

  NCT01698905· Phase 2· Novartis Pharmaceuticals· Source